This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (546)

Published on in Vol 7, No 10 (2018): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/10826, first published .
Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial

Authors of this article:

Laurie Zawertailo1, 2 Author Orcid Image ;   Tara Mansoursadeghi-Gilan1 Author Orcid Image ;   Helena Zhang1, 2 Author Orcid Image ;   Sarwar Hussain2 Author Orcid Image ;   Bernard Le Foll1, 3, 4, 5, 6, 7, 8 Author Orcid Image ;   Peter Selby2, 4, 9 Author Orcid Image
Article Authors Cited by (11) Tweetations (1) Metrics

Journals

  1. Lotfy N, Elsawah H, Hassan M. Topiramate for smoking cessation: Systematic review and meta-analysis. Tobacco Prevention & Cessation 2020;6(February) View
  2. Howes S, Hartmann-Boyce J, Livingstone-Banks J, Hong B, Lindson N. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2020;2021(5) View
  3. Krishnan N, Gu J, Abroms L. Mobile phone-based messaging for tobacco cessation in low and middle-income countries: A systematic review. Addictive Behaviors 2021;113:106676 View
  4. Zhang H, Gilbert E, Hussain S, Veldhuizen S, Le Foll B, Selby P, Zawertailo L. Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms. Nicotine & Tobacco Research 2022 View
  5. Zhang H, Mansoursadeghi-Gilan T, Hussain S, Veldhuizen S, Le Foll B, Selby P, Zawertailo L. Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study). Drug and Alcohol Dependence 2022;232:109312 View
  6. Novalen M, Chenoweth M, Zhao B, Hawk L, Tyndale R. Stability of Varenicline Concentration in Saliva Over 21 Days at Three Storage Temperatures. Nicotine & Tobacco Research 2022;24(2):270 View
  7. Giannoulis S, Chenoweth M, Saquilayan P, Tyndale R, Lerman C, Kennedy J, Zawertailo L, Gonçalves V. Examining the role of mitochondrial genetic variation in nicotine dependence. Psychiatry Research 2022;310:114452 View
  8. Livingstone-Banks J, Fanshawe T, Thomas K, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023;2023(5) View
  9. Livingstone-Banks J, Fanshawe T, Thomas K, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023;2024(5) View
  10. Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, Lindson N. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2023;2023(5) View
  11. de Jong A, Santa‐Ana‐Tellez Y, Zuidgeest M, Grupstra R, Jami F, de Boer A, Gardarsdottir H. Direct‐to‐participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers. British Journal of Clinical Pharmacology 2023;89(12):3512 View